IL28B rs12979860 T allele protects against CMV disease in liver transplant recipients in the post‐prophylaxis and late period
K Chmelova, S Frankova, M Jirsa… - Transplant Infectious …, 2019 - Wiley Online Library
Background Cytomegalovirus (CMV) disease represents a serious complication in liver
transplant (OLT) recipients. CMV prophylaxis reduces incidence of CMV disease in the early …
transplant (OLT) recipients. CMV prophylaxis reduces incidence of CMV disease in the early …
[PDF][PDF] IL28B rs12979860 T allele protects against CMV disease in liver transplant recipients in the post-prophylaxis and late period
K Chmelova, S Frankova, M Jirsa, M Neroldova… - academia.edu
Background: Cytomegalovirus (CMV) disease represents a serious complication in liver
transplant (OLT) recipients. CMV prophylaxis reduces incidence of CMV disease in the early …
transplant (OLT) recipients. CMV prophylaxis reduces incidence of CMV disease in the early …
IL28B rs12979860 T allele protects against CMV disease in liver transplant recipients in the post-prophylaxis and late period.
K Chmelova, S Frankova, M Jirsa, M Neroldova… - 2019 - cabidigitallibrary.org
Background: Cytomegalovirus (CMV) disease represents a serious complication in liver
transplant (OLT) recipients. CMV prophylaxis reduces incidence of CMV disease in the early …
transplant (OLT) recipients. CMV prophylaxis reduces incidence of CMV disease in the early …
IL28B rs12979860 T allele protects against CMV disease in liver transplant recipients in the post‐prophylaxis and late period.
K Chmelova, S Frankova, M Jirsa… - Transplant …, 2019 - search.ebscohost.com
Background: Cytomegalovirus (CMV) disease represents a serious complication in liver
transplant (OLT) recipients. CMV prophylaxis reduces incidence of CMV disease in the early …
transplant (OLT) recipients. CMV prophylaxis reduces incidence of CMV disease in the early …
IL28B rs12979860 T allele protects against CMV disease in liver transplant recipients in the post-prophylaxis and late period.
K Chmelova, S Frankova, M Jirsa… - … Infectious Disease: an …, 2019 - europepmc.org
Background Cytomegalovirus (CMV) disease represents a serious complication in liver
transplant (OLT) recipients. CMV prophylaxis reduces incidence of CMV disease in the early …
transplant (OLT) recipients. CMV prophylaxis reduces incidence of CMV disease in the early …
IL28B rs12979860 T allele protects against CMV disease in liver transplant recipients in the post-prophylaxis and late period
K Chmelova, S Frankova, M Jirsa… - … disease: an official …, 2019 - pubmed.ncbi.nlm.nih.gov
Background Cytomegalovirus (CMV) disease represents a serious complication in liver
transplant (OLT) recipients. CMV prophylaxis reduces incidence of CMV disease in the early …
transplant (OLT) recipients. CMV prophylaxis reduces incidence of CMV disease in the early …